Company comparison

BenevolentAI vs Altair

Radar profile, momentum bars, and stack placement side by side.

← Back to Compare

BenevolentAI
Not scored
momentum
Altair
Not scored
momentum
BenevolentAI capital
—
Altair capital
—
No radar series.

Momentum head-to-head

    Attribute tape

    FieldBenevolentAIAltair
    CategoryVertical applicationsVertical applications
    StackLayer 9Layer 9
    HQLondon, United KingdomTroy, Michigan, United States
    Founded20131985
    StatusOperatingAcquired
    Funding——
    Momentum——
    SummaryBenevolentAI is a clinical-stage TechBio company that uses AI, machine learning, and in-house wet-lab capabilities to accelerate drug discovery and development for complex diseases. Its Benevolent Platform™ powers both a proprietary therapeutic pipeline and external biopharma collaborations, including a partnership with AstraZeneca.Altair provides industrial software for simulation, high-performance computing (HPC), data analytics, and AI, helping engineers design better products and optimize processes. Originally publicly traded on NASDAQ (ALTR), Altair was acquired by Siemens in 2024 and is now integrated into the Siemens Xcelerator industrial software platform.
    Who forTeams evaluating AI vendors in this category.Teams evaluating AI vendors in this category.
    DifferentiatorBenevolentAI is a clinical-stage TechBio company that uses AI, machine learning, and in-house wet-lab capabilities to accelerate drug discovery and development for complex diseases. Its Benevolent Platform™ powers both a proprietary therapeutic pipeline and external biopharma collaborations, including a partnership with AstraZeneca.Altair provides industrial software for simulation, high-performance computing (HPC), data analytics, and AI, helping engineers design better products and optimize processes. Originally publicly traded on NASDAQ (ALTR), Altair was acquired by Siemens in 2024 and is now integrated into the Siemens Xcelerator industrial software platform.
    Open BenevolentAIOpen Altair